ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression

Autor: Hernández-Llodrà S, Juanpere N, de Muga S, Lorenzo M, Gil J, Font-Tello A, Agell L, Albero-González R, Segalés L, Merino J, Serrano L, Fumadó L, Cecchini L, Lloreta-Trull J

Publikováno v: Oncotarget
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

TMPRSS2 and SLC45A3 rearrangements may coexist in the same tumor. ERG rearrangements and PTEN loss are concomitant events in prostate cancer (PrCa), and can cooperate in progression. We have reported that mRNA expression of TMPRSS2-ERG and SLC45A3-ER

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::41df968e577417f008cdc8f086567d67
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15765

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cholesterol Regulates Syntaxin 6 Trafficking at trans-Golgi Network Endosomal Boundaries

Autor: Reverter, M. Rentero, C. Garcia-Melero, A. Hoque, M. Vilà de Muga, S. Álvarez-Guaita, A. Conway, J.R.W. Wood, P. Cairns, R. Lykopoulou, L. Grinberg, D. Vilageliu, L. Bosch, M. Heeren, J. Blasi, J. Timpson, P. Pol, A. Tebar, F. Murray, R.Z. Grewal, T. Enrich, C.

Inhibition of cholesterol export from late endosomes causes cellular cholesterol imbalance, including cholesterol depletion in the trans-Golgi network (TGN). Here, using Chinese hamster ovary (CHO) Niemann-Pick type C1 (NPC1) mutant cell lines and hu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::d131f87c3400bba5a69b883ceb9e83c5
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3087728

1636P - Ros1 Rearrangements and Copy Number Alterations in Nsclc Patients: High Frequency of Ros1 Deletions

Autor: Clavé, S., Gimeno, J., De Muga, S., Pijuan, L., Vidal, J., Lorenzo, M., Menendez, S., Taus, A., Muñoz-Mármol, A.M., Carcereny, E., Reguart, N., Mate, J.L., Serrano, S., Albanell, J., Espinet, B., Arriola, E., Salido, M.

Publikováno v: In Annals of Oncology September 2014 25 Supplement 4:iv566-iv566

Annexin A6 is a scaffold for PKCα to promote EGFR inactivation.

Autor: Koese, M, Rentero, C, Kota, B P, Hoque, M, Cairns, R, Wood, P, Vilà de Muga, S, Reverter, M, Alvarez-Guaita, A, Monastyrskaya, K, Hughes, W E, Swarbrick, A, Tebar, F, Daly, R J, Enrich, C, Grewal, T

Publikováno v: Oncogene; 6/6/2013, Vol. 32 Issue 23, p2858-2872, 15p, 3 Color Photographs, 3 Black and White Photographs, 1 Graph